300115 | Dox-NP™ (5mL vial)
Dox-NP™ (Liposomal Encapsulated Doxorubicin)
Dox-NP™ (5mL vial)
Dox-NP™ (Liposomal Encapsulated Doxorubicin)
Formulation: A Pegylated, long-circulating liposomal formulation with doxorubicin entrapped within an ammonium sulfate core via remote-loading. All unencapsulated was removed to yield a completely liposomal doxorubicin product. Liposomes are stored frozen for a longer shelf life.
Buffer: 10% w/v sucrose, 10 mM histidine buffer
Recommended applications: Intravenous (i.v.) injection in flank or orthotopic animal models of cancer
Storage conditions: Store frozen (-20ºC) until ready for use
Parot J, Caputo F, Mehn D, Hackley VA, Calzolai L. Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation. J Control Release. 2020 Jan 28;320:495-510. doi: 10.1016/j.jconrel.2020.01.049. Epub ahead of print. PMID: 32004590.
PubMed ID: 32004590- Certificate of Analysis (Lot No. 300115S-1EA-010 and 6565SAA010)
- Certificate of Analysis (Lot No. 300115S-1EA-011 and 6565SAA011)